PRF Technologies Ltd. reports developments across clinical-stage specialty pharmaceuticals and AI-driven solar analytics. The company focuses on reformulating established therapeutics for post-operative pain management and, through majority-owned LayerBio, is developing OcuRing™-K, a bio-erodible intraocular ring designed to deliver ketorolac for post-cataract pain and inflammation.
PRF news also covers the company’s DeepSolar business unit, which develops AI-driven digital asset management, forecasting, performance monitoring, and technical due diligence tools for utility-scale solar plants. Recurring updates include ocular drug-delivery regulatory milestones, preclinical and clinical safety data, patent activity, SaaS deployments, commercial collaborations, capital actions, and governance changes.
PRF Technologies (Nasdaq: PRFX) received a Nasdaq delisting determination on November 9, 2026, and requested a hearing that temporarily stays delisting.
Its closing bid price was below US$1.00 for 30 consecutive business days. A February 6, 2026 reverse split makes it ineligible for the normal 180-calendar-day compliance period. Shares continue trading pending the Panel’s decision. PRF intends to present a compliance plan that may include another reverse split. The Panel may grant an exception until May 8, 2027.
Preliminary unaudited cash and short-term deposits totaled approximately US$11.0 million at September 30, 2026. Majority-owned LayerBio expects Phase 2 OcuRing-K patient enrollment before year-end 2026. PRF is working toward the proposed GridFeed transaction with Dotz, subject to a non-binding term sheet and negotiation and execution of definitive agreements.
PRF Technologies (PRFX) signed a non-binding term sheet for Dotz Nano to commercialize and acquire its GridFeed energy platform for US$1.0 million. Dotz would operate GridFeed under an exclusive license from closing, with ownership and intellectual property transferring after US$650,000 is paid. PRF would invest US$250,000 in Dotz’s recently announced A$2.0 million placement. Dotz would employ the GridFeed team and fund operations from closing. Completion requires due diligence, both boards’ approval and definitive agreements.
PRF plans to direct resources toward healthcare programs. Preliminary, unaudited cash, including short-term deposits, was approximately US$11.0 million at September 30, 2026. Its majority-owned LayerBio subsidiary expects enrollment in the U.S. multi-center Phase 2 trial of OcuRing-K to begin before year-end. PRF also continues to advance its PRF-110 post-surgical pain candidate.
PRF Technologies (Nasdaq: PRFX) outlined plans to begin OcuRing-K Phase 2 enrollment and develop GridFeed as a standalone subsidiary. Preliminary, unaudited consolidated cash, including short-term deposits, was approximately $11.0 million at September 30, 2026, with approximately $2.5 million in liabilities. The nine-month operating loss was approximately $3.7 million; equity-line gross proceeds were approximately $10.5 million, including approximately $0.5 million in the third quarter.
Majority-owned LayerBio expects U.S. multi-center trial enrollment before year-end, after start-up activities, to evaluate pain, inflammation and safety following cataract surgery. PRF plans to establish GridFeed and DeepSolar as a wholly owned subsidiary for potential strategic transactions. GridFeed is evaluating AI data center power applications, while PRF has begun recognizing limited initial revenue from its first commercial engagements.
PRF Technologies (PRFX) announced that its AI-driven GridFeed platform is exploring the AI and hyperscale data center market as a strategic growth opportunity. The company believes GridFeed’s existing energy optimization engine, currently used for renewable assets and battery storage, can be adapted to help data center operators maximize the value of limited power capacity as electricity and grid constraints intensify.
Potential applications under evaluation include workload shifting, energy cost optimization, battery charge and discharge strategies, demand response and real-time power allocation. On September 9, 2026, PRF outlined plans to place GridFeed and DeepSolar into a standalone, wholly owned subsidiary, which it believes will give GridFeed more flexibility to pursue new markets and partnerships across the data center ecosystem.
PRF Technologies (PRFX) plans to establish GridFeed™, together with its DeepSolar operations, as a standalone, wholly owned subsidiary to focus on the growth and commercialization of its AI-driven renewable energy trading technology.
The new structure is intended to let GridFeed pursue strategic investments, partnerships and commercial collaborations directly with renewable producers, traders, utilities, technology firms and sector-focused investors. GridFeed’s platform uses DeepSolar’s AI engine, combining localized weather intelligence, production forecasting, battery storage orchestration and market analytics to support day-ahead, intraday and continuous trading decisions. The company reports validation of the AI engine with real-world European data, acceptance into the NVIDIA Connect program and filing of a patent application for plant-level microclimate forecasting. GridFeed will be showcased at Energy Trading Week Europe 2026 in London, while PRF continues healthcare programs and ended Q2 2026 with about $11.6 million in cash.
PRF Technologies (PRFX) reported first half 2026 results and a broad business update across its healthcare and AI energy segments.
In ophthalmology, the FDA cleared the IND for OcuRing™-K, enabling a U.S. multi-center Phase II cataract-surgery trial, with enrollment expected in the second half of 2026. In post-operative pain, PRF-110 showed sustained 72-hour analgesic activity comparable to ZYNRELEF® in a porcine model using a ropivacaine-only, NSAID-free formulation, with expanded data indicating slower systemic absorption and enhanced local tissue retention.
In energy, the DeepSolar platform added commercial collaborations, validated its Predict™ optimization engine on real-world European data, expanded into battery storage and unveiled the GridFeed™ trading platform, and began generating revenue from SaaS and service engagements. As of June 30, 2026, cash and equivalents were approximately $11.6 million, supported by a $10.0 million equity raise, while R&D spending increased and G&A expenses declined 39% year-over-year.
PRF Technologies (Nasdaq: PRFX) reported in a shareholder letter that it raised $10 million on May 28, 2026 through its equity line facility, which the company says substantially strengthened its balance sheet and increased strategic flexibility for growth initiatives.
The biotechnology subsidiary LayerBio is completing operational and clinical preparations for a planned Phase 2 trial of OcuRing-K, an ocular implant used during cataract surgery, while lead candidate PRF-110 showed expanded preclinical data with sustained 72-hour analgesic activity versus an approved extended-release benchmark.
In renewable energy, DeepSolar validated its Predict platform with European market data, added Battery-to-Revenue Intelligence for storage assets, joined the NVIDIA Connect program and plans to showcase GridFeed at Energy Trading Week Europe 2026.
PRF Technologies (Nasdaq: PRFX) announced that its DeepSolar business unit will participate in Energy Trading Week Europe 2026, held September 24–25, 2026 at the Business Design Centre in London. The event is expected to attract over 2,500 energy trading professionals.
PRF plans to showcase GridFeed™, its AI-driven platform for renewable energy trading, market participation and revenue optimization, built on the DeepSolar Predict AI engine. The company expects to present to traders, asset owners, operators and balancing responsible parties, join an industry panel and hold meetings with prospective customers and partners as part of its go-to-market strategy.
PRF Technologies (Nasdaq: PRFX) announced an expansion of its AI-driven renewable energy revenue optimization platform, DeepSolar Predict, adding a Battery-to-Revenue Intelligence capability that extends optimization workflows from solar assets to battery energy storage.
The new feature is designed to link storage availability, operating constraints and market conditions into decision-support workflows, supporting decisions on when to store, dispatch or preserve battery capacity. It follows recently completed real-world validation of DeepSolar Predict using European market data, as PRF advances the solution toward planned commercial launch and integrates it into its future GridFeed trading platform.
PRF Technologies (Nasdaq: PRFX) announced that its DeepSolar unit has completed initial validation of DeepSolar Predict, an AI-based revenue optimization platform for renewable energy markets.
The validation used real-world European-style utility-scale production, weather and market data across day-ahead and intraday scenarios as the platform progresses toward planned commercial launch.